Cite
APA Citation
Su, S., Cao, J., Meng, X., Liu, R., Vander Ark, A., Woodford, E., Zhang, R., Stiver, I., Zhang, X., Madaj, Z. B., Bowman, M. J., Wu, Y., Xu, H. E., Chen, B., Yu, H., & Li, X. (2022). enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases. Cancer letters, 525, 170–178. http://access.bl.uk/ark:/81055/vdc_100146767373.0x000036